Good morning, Shea
3 critical alerts · 8 clients with policy exposure
March 31, 2026
Policies Tracked
10
CMS rules & legislation
Clients Monitored
8
across healthcare sectors
Revenue at Risk
$5.2B
annual client exposure
Active Conflicts
3
cross-client tensions
Recent Changes
View all changesCMS Publishes Round 3 IRA Drug Negotiation List — 20 Additional Drugs
CMS published the final Round 3 list of 20 additional drugs for Medicare price negotiation under the IRA. 4 Pfizer products included: Eliquis, Ibrance, Prevnar 20, and Paxlovid. Therapeutic value assessment methodology finalized with 60-day comment period. Combined Round 1-3 scope: 50 drugs, $98B in Medicare spending.
NDAA Conference Report Released — $886B Defense Authorization
House and Senate Armed Services Committees released the FY2026 NDAA conference report. B-21 Raider fully funded at $7.2B, Sentinel GBSD at $3.8B. Includes new AUKUS technology sharing provisions, AI autonomous systems funding of $2.4B, and DoD cloud modernization framework. Floor votes expected within two weeks.
Senate Commerce Committee Passes Federal Data Privacy Act (18-8)
Senate Commerce Committee advanced the Comprehensive Federal Data Privacy Act with bipartisan support. Key provisions: individual data rights, opt-out of targeted advertising, algorithmic transparency, FTC enforcement, and state law preemption with floor for biometric/health data. Bill moves to full Senate.
EPA Publishes Final Power Plant Emissions Rule — Effective June 1
EPA published the final rule on power plant emissions standards in the Federal Register, triggering a 60-day effective date (June 1, 2026). Industry coalition led by API immediately announced legal challenge in D.C. Circuit. Rule requires 90% emissions reduction for new gas plants >400MW by 2032.
Senate Energy Committee Passes FERC LNG Permitting Reform (14-6)
Senate Energy & Natural Resources Committee advanced the FERC LNG Export Permitting Reform Act with bipartisan support. Establishes 18-month permitting timeline and categorical exclusions for existing terminal expansions. Cheniere's Stage 3 expansion specifically benefits from brownfield categorical exclusion.
Client Scoreboard
American Petroleum Institute
Energy
Pfizer Inc.
Pharmaceuticals
Northrop Grumman
Defense
Estée Lauder Companies
Consumer Goods
Cheniere Energy
Energy
Comcast Corporation
Telecommunications
Mastercard
Financial Services
Amazon.com Services LLC
Technology
United Airlines Inc.
Transportation
Memorial Sloan Kettering Cancer Center
Healthcare
Client Conflict Detected
American Petroleum Institute and Memorial Sloan Kettering Cancer Center have opposing interests on Section EPA-2026-0187 — EPA Emissions Standards — Energy Industry vs. Public Health